Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The study will identify the barriers and facilitators of implementation of the out-of-hospital administration of CAB+RPV LA from the point of view of staff participating in the study.
This substudy will use a qualitative descriptive approach based on Consolidated Framework for Implementation Research (CFIR). Data will be collected using semi-structured interviews among HOLA staff participants until achieving data saturation. Data will be analyzed using Braun & Clarke's thematic analysis method.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Qualitative Interview | Other | All study staff who participate in the substudy will be interviewed through a 40-50 minute-qualitative interview. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Qualitative Interview | Other | 40-50 minute-qualitative interview. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Identify the barriers and facilitators of implementation of the out-of-hospital administration of CAB+RPV LA from the point of view of staff participating in the study. | 1. To assess barriers and facilitators of implementation of the out-of-hospital administration of CAB+RPV LA from the point of view of staff participating in the HOLA study, at any time after the first 6 months of participation in the study. These will be assessed through a 40-50 minute-qualitative interview created for the study, which references the following domains: adaptability to the intervention, consideration of the needs of patients, changes in infrastructure, implementation climate (need of change, compatibility), preparation for implementation (leadership engagement and resource availability), individual characteristics, need for external agents, main stakeholders, execution and final considerations. | after the first 6 months of participation in the study |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria: NONE
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Germans Trias I Pujol Hospital | Badalona | Barcelona | 08916 | Spain | ||
| CAP Dr Robert |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 40733609 | Derived | Hernandez-Sanchez D, Leyva-Moral JM, Olalla J, Negredo E, On Behalf Of The Hola Study Group. Barriers and Facilitators of Implementation of the Non-Hospital-Based Administration of Long-Acting Cabotegravir Plus Rilpivirine in People with HIV: Qualitative Data from the HOLA Study. Viruses. 2025 Jul 16;17(7):993. doi: 10.3390/v17070993. |
Not provided
Not provided
Not provided
The substudy is a transversal, one arm, multicentric study including the staff participating in the HOLA study, to identify the barriers and facilitators of implementation of the out-of-hospital administration of CAB+RPV LA following a qualitative descriptive design.
All study staff who participate in the substudy will be interviewed through a 40-50 minute-qualitative interview
Not provided
Not provided
Not provided
Not provided
| Barcelona |
| 08001 |
| Spain |
| Centre de Salut Internacional i Malalties Transmissibles Drassanes - Vall d'Hebron | Barcelona | 08001 | Spain |
| BCN CheckPoint | Barcelona | 08015 | Spain |
| Hospital Vall D' Hebrón | Barcelona | 08035 | Spain |
| Cs Leganitos | Málaga | 29601 | Spain |
| Hospital Costa Del Sol | Málaga | 29603 | Spain |
| Cs San Luis de Sabinillas | Málaga | 29692 | Spain |
| Cs San Pedro de Alcántara | Málaga | 29692 | Spain |